Company Profile



ZXBio Co., Ltd is founded in 2017 at Mogan Mountain of Hi-Tech National Industry Development Zone, Huzhou. 

      Our company sets up a manufacturing base for producing top grade monoclonal antibody. Through a combination of intelligent-feedback software and indexed operational control system, we aim to establish an integrated manufacturing platform optimized for antibody production. The mission of our company is to develop monoclonal antibody-based research reagents, diagnostic reagents, and therapeutics for the global medical community. This could lead to job creation, efficient delivery of novel antibody-based drugs to patients of a variety of medical illness. 

Novel Business Philosophy

ZXBio pioneers a novel business philosophy of corporate indexation. By constructing all company holdings and operational procedures into a value index, ZXBio aims to maximize its value index through day to day operation. We believe this new strategy will maximize our company's efficiency to meet market needs and grow our company's value in the fastest way.


Yang Zhang, Ph.D, MBA, MPH, Chief Executive Officer, Chairperson


  • Education: Yale MPH/MBA, UCSF Immunology Ph.D
  • Expertise: Biotechnology, Finance, Quantitative Investment
  • Experience: Yale New Haven Hospital, Dr. Jason Cyster (HHMI investigator, member of National Academy of Science, member of American Academy of Arts and Sciences) Laboratory at UCSF Medical Center, China Reform Investment Co., LTD
  • Award: Qianjiang Talent Plan, the South Lake Taihu Elite Plan Award, Elected as HHMI International Student Research Fellowship
  • Featured Publication: Migratory and adhesive cues controlling innate-like lymphocyte surveillance of the pathogen-exposed surface of the lymph node (Cover Article for eLife August 2016 monthly archive)

Scientific Advisory Board


Jason Cyster is a professor of microbiology and immunology at the University of California, San Francisco. He has been a Howard Hughes Medical Institution (HHMI) Investigator for 19 years.


Mark Ansel is a professor of microbiology and immunology at the University of California, San Francisco. 


Lewis L. Lanier is a professor of microbiology and immunology at the University of California, San Francisco. He is the Chair and J. Michael Bishop, MD, Distinguished Professor of the Department of Microbiology and Immunology. He is a Member of the National Academy of Sciences. 

Disease Management

Focused Disease Areas


ZXBio develops monoclonal antibody reagents and drugs for 5 disease areas

Anti-Aging Therapy




Macular Degeneration




Cardiovascular Disease


Cell Shaker for Antibody Production